{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:44:07Z","timestamp":1790621047625,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T00:00:00Z","timestamp":1711843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1053\/j.jvca.2024.03.042","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T06:38:09Z","timestamp":1712039889000},"page":"1662-1672","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Anti-Xa-guided Anticoagulation With Unfractionated Heparin and Thrombosis During Extracorporeal Membrane Oxygenation Support: A Systematic Review and Meta-analysis"],"prefix":"10.1053","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6193-3662","authenticated-orcid":false,"given":"Sasa","family":"Rajsic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Breitkopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Treml","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragana","family":"Jadzic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3950-7262","authenticated-orcid":false,"given":"Nicole","family":"Innerhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Eckhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Oberleitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariha","family":"Nawabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoran","family":"Bukumiric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2024.03.042_bib0001","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/s13054-016-1570-4","article-title":"The inflammatory response to extracorporeal membrane oxygenation (ECMO): A review of the pathophysiology","volume":"20","author":"Millar","year":"2016","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2024.03.042_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11092314","article-title":"The role of excessive anticoagulation and missing hyperinflammation in ECMO-associated bleeding","volume":"11","author":"Rajsic","year":"2022","journal-title":"J Clin Med"},{"key":"10.1053\/j.jvca.2024.03.042_bib0003","doi-asserted-by":"crossref","unstructured":"Rajsic S, Breitkopf R, Jadzic D, et al. Anticoagulation strategies during extracorporeal membrane oxygenation: A narrative review. 2022;11:5147.","DOI":"10.3390\/jcm11175147"},{"key":"10.1053\/j.jvca.2024.03.042_bib0004","series-title":"Extracorporeal life support: The ELSO red book","author":"Brogan","year":"2017"},{"key":"10.1053\/j.jvca.2024.03.042_bib0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13613-016-0196-7","article-title":"Predictive factors of bleeding events in adults undergoing extracorporeal membrane oxygenation","volume":"6","author":"Aubron","year":"2016","journal-title":"Ann Intensive Care"},{"key":"10.1053\/j.jvca.2024.03.042_bib0006","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11051224","article-title":"ECMO predictors of mortality: A 10-year referral centre experience","volume":"11","author":"Treml","year":"2022","journal-title":"J Clin Med"},{"key":"10.1053\/j.jvca.2024.03.042_bib0007","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1007\/s00134-022-06723-z","article-title":"How to manage anticoagulation during extracorporeal membrane oxygenation","volume":"48","author":"Levy","year":"2022","journal-title":"Intensive Care Med"},{"key":"10.1053\/j.jvca.2024.03.042_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinane.2021.110330","article-title":"Systematic review and meta-analysis of the clinical effectiveness of point-of-care testing for anticoagulation management during ECMO","volume":"73","author":"Jiritano","year":"2021","journal-title":"J Clin Anesth"},{"key":"10.1053\/j.jvca.2024.03.042_bib0009","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13613-022-01067-9","article-title":"Extracorporeal membrane oxygenation for cardiogenic shock: A meta-analysis of mortality and complications","volume":"12","author":"Rajsic","year":"2022","journal-title":"Ann Intensive Care"},{"key":"10.1053\/j.jvca.2024.03.042_bib0010","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/0267659120952982","article-title":"Anti-Xa versus time-guided anticoagulation strategies in extracorporeal membrane oxygenation: A systematic review and meta-analysis","volume":"36","author":"Willems","year":"2021","journal-title":"Perfusion"},{"key":"10.1053\/j.jvca.2024.03.042_bib0011","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.cll.2014.06.014","article-title":"Management of anticoagulation and hemostasis for pediatric extracorporeal membrane oxygenation","volume":"34","author":"Saini","year":"2014","journal-title":"Clinics Lab Med"},{"key":"10.1053\/j.jvca.2024.03.042_bib0013","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MAT.0000000000001652","article-title":"2021 ELSO adult and pediatric anticoagulation guidelines","volume":"68","author":"McMichael","year":"2022","journal-title":"ASAIO J"},{"key":"10.1053\/j.jvca.2024.03.042_bib0014","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1053\/j.jvca.2024.03.042_bib0015","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1053\/j.jvca.2024.03.042_bib0016","series-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2000"},{"key":"10.1053\/j.jvca.2024.03.042_bib0017","doi-asserted-by":"crossref","first-page":"e12553","DOI":"10.1002\/rth2.12553","article-title":"Use of rotational thromboelastometry to predict hemostatic complications in pediatric patients undergoing extracorporeal membrane oxygenation: A retrospective cohort study","volume":"5","author":"Drop","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1053\/j.jvca.2024.03.042_bib0018","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.3390\/jcm10102158","article-title":"Evaluation of anti-activated factor x activity and activated partial thromboplastin time relations and their association with bleeding and thrombosis during veno-arterial ECMO support: A retrospective study","volume":"10","author":"Moussa","year":"2021","journal-title":"J Clin Med"},{"key":"10.1053\/j.jvca.2024.03.042_bib0019","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.685906","article-title":"Assessing anticoagulation in neonates with congenital diaphragmatic hernia during extracorporeal membrane oxygenation: Does Anti-factor Xa or thromboelastometry provide additional benefit?","volume":"9","author":"Perez Ortiz","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1053\/j.jvca.2024.03.042_bib0020","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/MAT.0000000000000811","article-title":"Impact of anticoagulation and circuit technology on complications during extracorporeal membrane oxygenation","volume":"65","author":"Niebler","year":"2019","journal-title":"ASAIO J"},{"key":"10.1053\/j.jvca.2024.03.042_bib0021","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1051\/ject\/201850149","article-title":"Use of thromboelastography to predict thrombotic complications in pediatric and neonatal extracorporeal membranous oxygenation","volume":"50","author":"Henderson","year":"2018","journal-title":"J Extra Corpor Technol"},{"key":"10.1053\/j.jvca.2024.03.042_bib0022","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.1097\/PCC.0000000000000101","article-title":"Unfractionated heparin activity measured by anti-factor Xa levels is associated with the need for extracorporeal membrane oxygenation circuit\/membrane oxygenator change: A retrospective pediatric study","volume":"15","author":"Irby","year":"2014","journal-title":"Pediatr Crit Care Med"},{"key":"10.1053\/j.jvca.2024.03.042_bib0023","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MAT.0000000000000204","article-title":"Anti-Xa directed protocol for anticoagulation management in children supported with extracorporeal membrane oxygenation","volume":"61","author":"O'Meara","year":"2015","journal-title":"ASAIO J"},{"key":"10.1053\/j.jvca.2024.03.042_bib0024","doi-asserted-by":"crossref","DOI":"10.1177\/02676591231185009","article-title":"Anti-Xa testing for pediatric and neonatal patients on extracorporeal membrane oxygenation","author":"Meshulami","year":"2023","journal-title":"Perfusion"},{"key":"10.1053\/j.jvca.2024.03.042_bib0025","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/vox.12514","article-title":"Adult extracorporeal membrane oxygenation: An international survey of transfusion and anticoagulation techniques","volume":"112","author":"Esper","year":"2017","journal-title":"Vox Sanguinis"},{"key":"10.1053\/j.jvca.2024.03.042_bib0026","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1097\/PCC.0b013e31827127e4","article-title":"Variability in anticoagulation management of patients on extracorporeal membrane oxygenation: An international survey","volume":"14","author":"Bembea","year":"2013","journal-title":"Pediatr Crit Care Med"},{"key":"10.1053\/j.jvca.2024.03.042_bib0027","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jcrc.2017.02.014","article-title":"Anticoagulation practices and the prevalence of major bleeding, thromboembolic events, and mortality in venoarterial extracorporeal membrane oxygenation: A systematic review and meta-analysis","volume":"39","author":"Sy","year":"2017","journal-title":"J Crit Care"},{"key":"10.1053\/j.jvca.2024.03.042_bib0028","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.3390\/jcm12093224","article-title":"Association of aPTT-guided anticoagulation monitoring with thromboembolic events in patients receiving V-A ECMO support: A systematic review and meta-analysis","volume":"12","author":"Rajsic","year":"2023","journal-title":"J Clin Med"},{"key":"10.1053\/j.jvca.2024.03.042_bib0029","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1345\/aph.1Q161","article-title":"Activated partial thromboplastin time versus antifactor Xa heparin assay in monitoring unfractionated heparin by continuous intravenous infusion","volume":"45","author":"Guervil","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1053\/j.jvca.2024.03.042_bib0030","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1345\/aph.1R635","article-title":"Discordant aPTT and anti-Xa values and outcomes in hospitalized patients treated with intravenous unfractionated heparin","volume":"47","author":"Price","year":"2013","journal-title":"Ann Pharmacother"},{"key":"10.1053\/j.jvca.2024.03.042_bib0031","first-page":"253","article-title":"Activated partial thromboplastin time monitoring of unfractionated heparin therapy: Issues and recommendations","volume":"43","author":"Marlar","year":"2017","journal-title":"Semin Thromb Hemost"},{"key":"10.1053\/j.jvca.2024.03.042_bib0032","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s11239-019-01879-w","article-title":"Influence of factor XII deficiency on activated partial thromboplastin time (aPTT) in critically ill patients","volume":"48","author":"Bachler","year":"2019","journal-title":"J Thromb Thrombol"},{"key":"10.1053\/j.jvca.2024.03.042_bib0033","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1600-0609.2008.01191.x","article-title":"Contact factor deficiencies and cardiopulmonary bypass surgery: Detection of the defect and monitoring of heparin","volume":"82","author":"van Veen","year":"2009","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.jvca.2024.03.042_bib0034","doi-asserted-by":"crossref","first-page":"e1206","DOI":"10.1097\/CCM.0000000000005179","article-title":"Prevalence and clinical impact of reduced coagulation factor xii activity in patients receiving extracorporeal membrane oxygenation","volume":"49","author":"Buchtele","year":"2021","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2024.03.042_bib0035","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/0267659120952982","article-title":"Anti-Xa versus time-guided anticoagulation strategies in extracorporeal membrane oxygenation: A systematic review and meta-analysis","volume":"36","author":"Willems","year":"2021","journal-title":"Perfusion"},{"key":"10.1053\/j.jvca.2024.03.042_bib0036","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.thromres.2021.10.010","article-title":"Comparison of clinical outcomes using activated partial thromboplastin time versus antifactor-Xa for monitoring therapeutic unfractionated heparin: A systematic review and meta-analysis","volume":"208","author":"Swayngim","year":"2021","journal-title":"Thromb Res"},{"key":"10.1053\/j.jvca.2024.03.042_bib0037","doi-asserted-by":"crossref","unstructured":"Wu T, Xia X, Chen W, et al. The effect of anti-Xa monitoring on the safety and efficacy of low-molecular-weight heparin anticoagulation therapy: A systematic review and meta-analysis. 2020;45:602-8.doi:10.1111\/jcpt.13169.","DOI":"10.1111\/jcpt.13169"},{"key":"10.1053\/j.jvca.2024.03.042_bib0038","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archinte.1994.00420010073009","article-title":"A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin","volume":"154","author":"Levine","year":"1994","journal-title":"Arch Internal Med"},{"key":"10.1053\/j.jvca.2024.03.042_bib0039","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/02676591221150880","article-title":"Outcomes of heparinized adult veno-arterial extracorporeal membrane oxygenation patients managed with low and high activated partial thromboplastin time targets: A systematic review and meta-analysis","volume":"39","author":"Mazzeffi","year":"2024","journal-title":"Perfusion"},{"key":"10.1053\/j.jvca.2024.03.042_bib0040","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.thromres.2019.05.006","article-title":"Routine laboratory measures of heparin anticoagulation for children on extracorporeal membrane oxygenation: Systematic review and meta-analysis","volume":"179","author":"Padhya","year":"2019","journal-title":"Thromb Res"},{"key":"10.1053\/j.jvca.2024.03.042_bib0041","first-page":"1176","article-title":"The natural history of direct hyperbilirubinemia associated with extracorporeal membrane oxygenation","volume":"146","author":"Walsh-Sukys","year":"1992","journal-title":"Am J Dis Children"},{"key":"10.1053\/j.jvca.2024.03.042_bib0042","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/MAT.0b013e31822e2475","article-title":"Hemolysis during cardiac extracorporeal membrane oxygenation: A case-control comparison of roller pumps and centrifugal pumps in a pediatric population","volume":"57","author":"Byrnes","year":"2011","journal-title":"ASAIO J"},{"key":"10.1053\/j.jvca.2024.03.042_bib0043","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.5858\/arpa.2013-0572-OA","article-title":"The influence of free hemoglobin and bilirubin on heparin monitoring by activated partial thromboplastin time and anti-Xa assay","volume":"138","author":"Kostousov","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.jvca.2024.03.042_bib0044","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13613-017-0275-4","article-title":"Systematic review and meta-analysis of complications and mortality of veno-venous extracorporeal membrane oxygenation for refractory acute respiratory distress syndrome","volume":"7","author":"Vaquer","year":"2017","journal-title":"Ann Intensive Care"},{"key":"10.1053\/j.jvca.2024.03.042_bib0045","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1177\/039139880602901205","article-title":"Autopsy findings in patients on postcardiotomy extracorporeal membrane oxygenation (ECMO)","volume":"29","author":"Rastan","year":"2006","journal-title":"Int J Artif Organs"},{"key":"10.1053\/j.jvca.2024.03.042_bib0046","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.3390\/jcm12093224","article-title":"Association of aPTT-guided anticoagulation monitoring with thromboembolic events in patients receiving V-A ECMO support: A systematic review and meta-analysis","volume":"12","author":"Rajsic","year":"2023","journal-title":"J Clin Med"},{"key":"10.1053\/j.jvca.2024.03.042_bib0047","doi-asserted-by":"crossref","first-page":"e964","DOI":"10.1097\/CCM.0000000000001865","article-title":"In-hospital neurologic complications in adult patients undergoing venoarterial extracorporeal membrane oxygenation: Results from the Extracorporeal Life Support Organization Registry,","volume":"44","author":"Lorusso","year":"2016","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2024.03.042_bib0048","doi-asserted-by":"crossref","first-page":"e897","DOI":"10.1097\/CCM.0000000000004498","article-title":"Modifiable risk factors and mortality from ischemic and hemorrhagic strokes in patients receiving venoarterial extracorporeal membrane oxygenation: Results from the Extracorporeal Life Support Organization Registry","volume":"48","author":"Cho","year":"2020","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2024.03.042_bib0049","unstructured":"Extracorporeal Life Support Organization (ELSO). Registry Report on Extracorporeal Life Support, International Summary. Accessed 16 December 2023. Available at: https:\/\/www.elso.org\/Registry\/InternationalSummaryandReports\/InternationalSummary.aspx"},{"key":"10.1053\/j.jvca.2024.03.042_bib0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13054-021-03554-0","article-title":"Anti-Xa activity and hemorrhagic events under extracorporeal membrane oxygenation (ECMO): A multicenter cohort study","volume":"25","author":"Descamps","year":"2021","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2024.03.042_bib0051","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/MAT.0000000000001246","article-title":"Activated partial thromboplastin time versus anti-factor xa monitoring of heparin anticoagulation in adult venoarterial extracorporeal membrane oxygenation patients","volume":"67","author":"Kulig","year":"2021","journal-title":"ASAIO J"},{"key":"10.1053\/j.jvca.2024.03.042_bib0052","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MAT.0000000000001004","article-title":"Evaluation of anti-Xa and activated partial thromboplastin time monitoring of heparin in adult patients receiving extracorporeal membrane oxygenation support","volume":"66","author":"Arnouk","year":"2020","journal-title":"ASAIO J"},{"key":"10.1053\/j.jvca.2024.03.042_bib0053","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13054-020-2726-9","article-title":"Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO","volume":"24","author":"Chlebowski","year":"2020","journal-title":"Crit Care"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077024002349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077024002349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T01:44:13Z","timestamp":1720835053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077024002349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1053077024002349"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2024.03.042","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-Xa-guided Anticoagulation With Unfractionated Heparin and Thrombosis During Extracorporeal Membrane Oxygenation Support: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2024.03.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}